| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.12B | -14.9% |
| Cost of Revenue | $486.4M | -12.8% |
| Gross Profit | $630.8M | -16.4% |
| R&D Expense | $211.9M | -1.1% |
| SG&A Expense | $99.9M | +11.1% |
| Operating Income | -$65.2M | -160.2% |
| Interest Expense | $17.0M | -2.3% |
| Pre-tax Income | -$77.5M | -182.4% |
| Income Tax | $8.5M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $156.7M | -33.3% |
| Accounts Receivable | $89.5M | -50.8% |
| Inventory | $141.0M | +58.4% |
| Current Assets | $466.9M | -19.0% |
| Total Assets | $1.04B | -8.7% |
| Current Liabilities | $517.6M | -10.1% |
| Long-term Debt | $190.0M | -15.6% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $55.5M | -77.7% |
| Capital Expenditures | $18.1M | +31.3% |
| Investing Cash Flow | -$18.1M | -31.3% |
| Financing Cash Flow | -$115.0M | +41.0% |
| Free Cash Flow | $37.4M | -84.1% |
| -47.2% |
| Net Income | -$86.0M | -210.1% |
| EPS (Basic) | -$0.66 | -210.0% |
| EPS (Diluted) | -$0.66 | -213.8% |
| Stockholders' Equity |
| $25.3M |
| -78.3% |